Ohio Public Employees Retirement System (OPERS)’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
27,885
+543
| +2% | +$19.7K | ﹤0.01% | 1335 |
|
|
2025
Q1 | $990K | Sell |
27,342
-3,163
| -10% | -$115K | ﹤0.01% | 1315 |
|
|
2024
Q4 | $1.28M | Sell |
30,505
-2,229
| -7% | -$93.8K | ﹤0.01% | 1282 |
|
|
2024
Q3 | $1.82M | Sell |
32,734
-538
| -2% | -$29.9K | 0.01% | 1096 |
|
|
2024
Q2 | $1.37M | Buy |
33,272
+3,198
| +11% | +$131K | 0.01% | 1083 |
|
|
2024
Q1 | $1.4M | Sell |
30,074
-2,836
| -9% | -$132K | 0.01% | 1060 |
|
|
2023
Q4 | $1.57M | Buy |
32,910
+5,359
| +19% | +$256K | 0.01% | 1060 |
|
|
2023
Q3 | $982K | Sell |
27,551
-3,051
| -10% | -$109K | ﹤0.01% | 1132 |
|
|
2023
Q2 | $1.41M | Sell |
30,602
-24,743
| -45% | -$1.14M | 0.01% | 1092 |
|
|
2023
Q1 | $2.22M | Sell |
55,345
-1,031
| -2% | -$41.3K | 0.01% | 961 |
|
|
2022
Q4 | $2.61M | Buy |
56,376
+18,525
| +49% | +$858K | 0.01% | 907 |
|
|
2022
Q3 | $1.57M | Buy |
37,851
+4,604
| +14% | +$191K | 0.01% | 1113 |
|
|
2022
Q2 | $1.98M | Sell |
33,247
-2,776
| -8% | -$166K | 0.01% | 1067 |
|
|
2022
Q1 | $2.62M | Sell |
36,023
-1,229
| -3% | -$89.3K | 0.01% | 1019 |
|
|
2021
Q4 | $3.13M | Sell |
37,252
-734
| -2% | -$61.7K | 0.01% | 952 |
|
|
2021
Q3 | $3.43M | Sell |
37,986
-290
| -0.8% | -$26.2K | 0.01% | 930 |
|
|
2021
Q2 | $3.65M | Buy |
38,276
+37,066
| +3,063% | +$3.53M | 0.01% | 909 |
|
|
2021
Q1 | $138K | Hold |
1,210
| – | – | ﹤0.01% | 1581 |
|
|
2020
Q4 | $168K | Sell |
1,210
-158
| -12% | -$21.9K | ﹤0.01% | 1462 |
|
|
2020
Q3 | $112K | Buy |
+1,368
| New | +$112K | ﹤0.01% | 1475 |
|